Fluorouracil






6619 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 11889 Use of an elemental diet in animals during treatment with 5-fluorouracil (NSC-19893). Cancer Treat Rep 1976 Jan 1
2 12865 Dissociation of 5-fluorouracil uptake from intracellular pH in Walker 256 carcinosarcoma. Cancer Treat Rep 1976 Jul 3
3 83561 [Chemotherapy of gastrointestinal tumors (review of the literature)]. Onkologie 1978 Dec 1
4 98910 Cell proliferation in dimethylhydrazine-induced colonic adenocarcinomata following cytotoxic drug treatment. Virchows Arch B Cell Pathol 1978 Aug 25 1
5 132786 [Adriamycin, cyclophosphamide, and 5-fluorouracil in the treatment of metastasizing breast cancer (author's transl)]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976 Jun 15 1
6 165496 Free radicals formed by exposure of pyrimidine solids to sodium atoms: an electron spin resonance study. Proc Natl Acad Sci U S A 1975 Mar 2
7 195585 Uridine kinase activities and pyrimidine nucleoside phosphorylation in fluoropyrimidine-sensitive and -resistant cell lines of the Novikoff hepatoma. Biochem J 1977 May 15 1
8 378768 [Effect of ftorafur and 5-fluorouracil on the chromosomes of human tumor cell cultures]. Genetika 1979 2
9 378934 Apparent involvement of purines in the control of expression of Salmonella typhimurium pyr genes: analysis of a leaky guaB mutant resistant to pyrimidine analogs. J Bacteriol 1979 Jun 1
10 446187 Effects of 5-fluorouracil on the thiamin status of adult female rats. Chemotherapy 1979 1
11 510847 Significance of estrogen receptor assay in cytotoxic chemotherapy in relation to previous endocrine therapy of advanced breast cancer patients. Gan 1979 Aug 1
12 623430 Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clin Lab Sci 1978 Jan-Feb 2
13 879810 Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil. Arch Dermatol 1977 Jul 2
14 1003701 Antitumor agents. I. Effect of 5-fluorouracil and cyclophosphamide on liver microsomes and thymus of rat. Jpn J Pharmacol 1976 Aug 2
15 1212650 Arylsulfatse B in colorectal cancer. Cancer 1975 Dec 1
16 1257062 [5-fluorouracil effectiveness and toxicity in the treatment of digestive trac.t neoplasms as a function of the mode of administration]. Nowotwory 1976 Jan-Mar 1
17 1280628 Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice. Int J Immunopharmacol 1992 Oct 1
18 1281687 In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 1992 Dec 15 8
19 1304835 [Dihydropyrimidine dehydrogenase activity in lymphocytes: predictive factor for 5-fluorouracil clearance]. Bull Cancer 1992 9
20 1333262 1H NMR spectroscopy of subcutaneous tumors in mice: preliminary studies of effects of growth, chemotherapy and blood flow reduction. NMR Biomed 1992 Sep-Oct 1
21 1333263 Studies of human tumors by MRS: a review. NMR Biomed 1992 Sep-Oct 1
22 1333267 Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B. Ann Oncol 1992 Nov 1
23 1351538 Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992 Jul 1
24 1355336 Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen. Gan To Kagaku Ryoho 1992 Jul 2
25 1370257 A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity. Clin Immunol Immunopathol 1992 Jan 1
26 1371964 Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice. Exp Hematol 1992 Feb 1
27 1372030 Transforming growth factor beta inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int J Cell Cloning 1992 Mar 1
28 1372764 Antineoplastic activity of the combination of 5-fluorouracil and interferon: preclinical and clinical results. Semin Oncol 1992 Apr 5
29 1373051 [Successfully treated locally advanced breast cancer by intra-arterial infusion chemotherapy: a case report]. Gan To Kagaku Ryoho 1992 Apr 1
30 1373685 Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 1992 Mar 1
31 1374741 Protective effect of SPR-901 (RBS) on the decrease of peripheral leukocyte number in 5-fluorouracil-treated mice. Int J Immunopharmacol 1992 Jan 5
32 1378737 Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue. Correlation of antitumor activity with dosage and FUra incorporation into RNA. Biochem Pharmacol 1992 Jun 23 4
33 1379119 Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination. Cancer Res 1992 Aug 1 1
34 1379852 Evidence that stem cell factor is involved in the rebound thrombocytosis that follows 5-fluorouracil treatment. Blood 1992 Aug 15 2
35 1382702 Stem cell factor enhances proliferation, but not maturation, of murine megakaryocytic progenitors in serum-free culture. Blood 1992 Oct 1 2
36 1394037 Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma. Cancer 1992 Oct 15 1
37 1406088 Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy. Magn Reson Imaging 1992 1
38 1406460 Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model. Med Microbiol Immunol 1992 1
39 1417007 [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer]. Gan To Kagaku Ryoho 1992 Oct 1
40 1421872 Interferon alpha-2a shows antitumor activity in combination with 5-fluorouracil against human colon carcinoma xenografts: a study in reference to thymidylate synthetase activity inhibition. Surg Today 1992 4
41 1423296 Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line. Cancer Res 1992 Dec 1 2
42 1425012 Actions of leukaemia inhibitory factor on megakaryocyte and platelet formation. Ciba Found Symp 1992 1
43 1433371 Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a. J Natl Cancer Inst 1992 Dec 2 3
44 1435214 Determination of absolute phosphate metabolite concentrations in RIF-1 tumors in vivo by 31P-1H-2H NMR spectroscopy using water as an internal intensity reference. Magn Reson Med 1992 Nov 1
45 1447313 Interferon-gamma inhibits proliferation, but not commitment, of murine granulocyte-macrophage progenitors. J Cell Physiol 1992 Dec 2
46 1449107 Phase I study of 5-fluorouracil with folinic acid combined with recombinant human granulocyte-macrophage colony-stimulating factor. Am J Clin Oncol 1992 Dec 2
47 1449968 In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review. NMR Biomed 1992 Sep-Oct 1
48 1451052 Schedule-dependent inhibition of thymidylate synthase by 5-fluorouracil in gastric cancer. Cancer 1992 Dec 15 3
49 1457523 Antimetabolites. Curr Opin Oncol 1992 Dec 1
50 1469133 Hyperkeratosis lenticularis perstans (Flegel's disease). Ultrastructural study of lesional and perilesional skin and therapeutic trial of topical tretinoin versus 5-fluorouracil. J Am Acad Dermatol 1992 Nov 1